{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T17:08:32Z","timestamp":1776272912495,"version":"3.50.1"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T00:00:00Z","timestamp":1548806400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31300137"],"award-info":[{"award-number":["31300137"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12933-019-0817-1","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T07:02:42Z","timestamp":1548831762000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Comparative effects of lipid lowering, hypoglycemic, antihypertensive and antiplatelet medications on carotid artery intima-media thickness progression: a network meta-analysis"],"prefix":"10.1186","volume":"18","author":[{"given":"Rongzhong","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerry","family":"Mills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zicheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,30]]},"reference":[{"issue":"9491","key":"817_CR1","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","volume":"366","author":"KG Alberti","year":"2005","unstructured":"Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group. The metabolic syndrome\u2014a new worldwide definition. Lancet. 2005;366(9491):1059\u201362.","journal-title":"Lancet"},{"issue":"3","key":"817_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.arcmed.2004.12.003","volume":"36","author":"CA Aguilar-Salinas","year":"2005","unstructured":"Aguilar-Salinas CA, Rojas R, G\u00f3mez-P\u00e9rez FJ, Mehta R, Franco A, Olaiz G, et al. The metabolic syndrome: a concept hard to define. Arch Med Res. 2005;36(3):223\u201331.","journal-title":"Arch Med Res"},{"issue":"9831","key":"817_CR3","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/S0140-6736(12)60441-3","volume":"379","author":"MW Lorenz","year":"2012","unstructured":"Lorenz MW, Polak JF, Kavousi M, Mathiesen EB, V\u00f6lzke H, Tuomainen TP, et al. Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data. Lancet. 2012;379(9831):2053\u201362.","journal-title":"Lancet"},{"issue":"1","key":"817_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/aje\/155.1.38","volume":"155","author":"LE Chambless","year":"2002","unstructured":"Chambless LE, Folsom AR, Davis V, Sharrett R, Heiss G, Sorlie P, et al. Risk factors for progression of common carotid atherosclerosis: the Atherosclerosis Risk in Communities Study, 1987\u20131998. Am J Epidemiol. 2002;155(1):38\u201347.","journal-title":"Am J Epidemiol"},{"key":"817_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1475-2840-9-40","volume":"9","author":"L Lundby-Christensen","year":"2010","unstructured":"Lundby-Christensen L, Almdal TP, Carstensen B, Tarnow L, Wiinberg N. Carotid intima-media thickness in individuals with and without type 2 diabetes: a reproducibility study. Cardiovasc Diabetol. 2010;9:40. https:\/\/doi.org\/10.1186\/1475-2840-9-40 .","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"817_CR6","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/jdi.12559","volume":"8","author":"T Mita","year":"2017","unstructured":"Mita T, Katakami N, Shiraiwa T, Yoshii H, Gosho M, Shimomura I, et al. Changes in carotid intima-media thickening in patients with type 2 diabetes mellitus: subanalysis of the Sitagliptin Preventive Study of Intima-Media Thickness Evaluation. J Diabetes Investig. 2017;8(2):254\u20135.","journal-title":"J Diabetes Investig."},{"issue":"2","key":"817_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1177\/1741826710389400","volume":"18","author":"SA Peters","year":"2011","unstructured":"Peters SA, Grobbee DE, Bots ML. Carotid intima\u2013media thickness: a suitable alternative for cardiovascular risk as outcome? Eur J Cardiovasc Prev Rehabil. 2011;18(2):167\u201374.","journal-title":"Eur J Cardiovasc Prev Rehabil."},{"key":"817_CR8","unstructured":"Barendregt JJ, Doi SA. MetaXL Version 5.3. User Guide. EpiGear International Pty Ltd. http:\/\/www.epigear.com ."},{"issue":"Pt A","key":"817_CR9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.cct.2015.05.009","volume":"45","author":"SA Doi","year":"2015","unstructured":"Doi SA, Barendregt JJ, Khan S, Thalib L, Williams GM. Advances in the meta-analysis of heterogeneous clinical trials I: the inverse variance heterogeneity model. Contemp Clin Trials. 2015;45(Pt A):130\u20138.","journal-title":"Contemp Clin Trials."},{"issue":"2","key":"817_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1136\/eb-2015-102088","volume":"18","author":"D Mavridis","year":"2015","unstructured":"Mavridis D, Giannatsi M, Cipriani A, Salanti G. A primer on network meta-analysis with emphasis on mental health. Evid Based Ment Health. 2015;18(2):40\u20136.","journal-title":"Evid Based Ment Health."},{"issue":"5","key":"817_CR11","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s00380-010-0093-1","volume":"26","author":"CM Ahn","year":"2011","unstructured":"Ahn CM, Hong SJ, Park JH, Kim JS, Lim DS. Cilostazol reduces the progression of carotid intima-media thickness without increasing the risk of bleeding in patients with acute coronary syndrome during a 2-year follow-up. Heart Vessels. 2011;26(5):502\u201310.","journal-title":"Heart Vessels"},{"issue":"1","key":"817_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0168-8227(00)00235-7","volume":"52","author":"CW Ahn","year":"2001","unstructured":"Ahn CW, Lee HC, Park SW, Song YD, Huh KB, Oh SJ, et al. Decrease in carotid intima media thickness after 1\u00a0year of cilostazol treatment in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2001;52(1):45\u201353.","journal-title":"Diabetes Res Clin Pract"},{"issue":"9","key":"817_CR13","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1161\/01.STR.0000236839.69658.c5","volume":"37","author":"B Ariff","year":"2006","unstructured":"Ariff B, Zambanini A, Vamadeva S, Barratt D, Xu Y, Sever P, et al. Candesartan- and atenolol-based treatments induce different patterns of carotid artery and left ventricular remodeling in hypertension. Stroke. 2006;37(9):2381\u20134.","journal-title":"Stroke"},{"issue":"3","key":"817_CR14","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1161\/01.STR.0000155731.92786.e9","volume":"36","author":"FW Asselbergs","year":"2005","unstructured":"Asselbergs FW, van Roon AM, Hillege HL, de Jong PE, Gans RO, Smit AJ, et al. Effects of fosinopril and pravastatin on carotid intima-media thickness in subjects with increased albuminuria. Stroke. 2005;36(3):649\u201353.","journal-title":"Stroke"},{"issue":"1","key":"817_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2147\/VHRM.S3409","volume":"5","author":"JP Baguet","year":"2009","unstructured":"Baguet JP, Asmar R, Valensi P, Nissedurgeat S, Mallion JM. Effects of candesartan cilexetil on carotid remodeling in hypertensive diabetic patients: the MITEC study. Vascular Health Risk Manag. 2009;5(1):175\u201383.","journal-title":"Vascular Health Risk Manag."},{"key":"817_CR16","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.2337\/diacare.27.12.2887","volume":"27","author":"ED Beishuizen","year":"2004","unstructured":"Beishuizen ED, van de Ree MA, Jukema JW, Tamsma JT, van der Vijver JCM, Meinders AE, et al. Two-year statin therapy does not alter the progression of intima-media thickness in patients with type 2 diabetes without manifest cardiovascular disease. Diabetes Care. 2004;27:2887\u201392.","journal-title":"Diabetes Care"},{"issue":"6","key":"817_CR17","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/j.1365-2796.2009.02073.x","volume":"265","author":"ML Bots","year":"2010","unstructured":"Bots ML, Palmer MK, Dogan S, Plantinga Y, Raichlen JS, Evans GW, et al. Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12\u00a0months of treatment: the METEOR study. J Intern Med. 2010;265(6):698\u2013707.","journal-title":"J Intern Med"},{"key":"817_CR18","doi-asserted-by":"publisher","first-page":"40C","DOI":"10.1016\/S0002-9149(99)80469-X","volume":"76","author":"E Groot de","year":"1995","unstructured":"de Groot E, Jukema JW, van Boven AJ, Reiber JH, Zwinderman AH, Lie KI, et al. Effect of pravastatin on progression and regression of coronary atherosclerosis and vessel wall changes in carotid and femoral arteries: a report from the Regression Growth Evaluation Statin Study. Am J Cardiol. 1995;76:40C\u20136C.","journal-title":"Am J Cardiol"},{"key":"817_CR19","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2337\/diacare.21.4.641","volume":"21","author":"RS Elkeles","year":"1998","unstructured":"Elkeles RS, Diamond JR, Poulter C, Dhanjil S, Nicolaides AN, Mahmood S, et al. Cardiovascular outcomes in type 2 diabetes: a double-blind placebo-controlled study of bezafibrate: the St. Mary\u2019s, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) study. Diabetes Care. 1998;21:641\u20138.","journal-title":"Diabetes Care."},{"issue":"5","key":"817_CR20","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1161\/01.STR.0000125864.01546.f2","volume":"35","author":"M Hanefeld","year":"2004","unstructured":"Hanefeld M, Chiasson JL, Koehler C, Henkel E, Schaper F, Temelkova-Kurktschiev T. Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance. Stroke. 2004;35(5):1073\u20138.","journal-title":"Stroke"},{"issue":"13","key":"817_CR21","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1161\/01.CIR.103.13.1721","volume":"103","author":"B Hedblad","year":"2001","unstructured":"Hedblad B, Wikstrand J, Janzon L, Wedel H, Berglund G. Low-dose metoprolol CR\/XL and fluvastatin slow progression of carotid intima-media thickness: main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS). Circulation. 2001;103(13):1721\u20136.","journal-title":"Circulation"},{"issue":"3","key":"817_CR22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1365-2796.2007.01767.x","volume":"261","author":"B Hedblad","year":"2007","unstructured":"Hedblad B, Zambanini A, Nilsson P, Janzon L, Berglund G. Rosiglitazone and carotid IMT progression rate in a mixed cohort of patients with type 2 diabetes and the insulin resistance syndrome: main results from the Rosiglitazone Atherosclerosis Study. J Intern Med. 2007;261(3):293\u2013305.","journal-title":"J Intern Med"},{"issue":"25","key":"817_CR23","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1016\/j.jacc.2008.09.049","volume":"52","author":"A Hiukka","year":"2008","unstructured":"Hiukka A, Westerbacka J, Leinonen ES, Hulten LM, Taskinen MR, Hiukka A, et al. Long-term effects of fenofibrate on carotid intima-media thickness and augmentation index in subjects with type 2 diabetes mellitus. J Am College Cardiol. 2008;52(25):2190\u20137.","journal-title":"J Am College Cardiol."},{"issue":"7","key":"817_CR24","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.2337\/dc05-2462","volume":"29","author":"HN Hodis","year":"2006","unstructured":"Hodis HN, Mack WJ, Zheng L, Li Y, Torres M, Sevilla D, et al. Effect of peroxisome proliferator-activated receptor gamma agonist treatment on subclinical atherosclerosis in patients with insulin-requiring type 2 diabetes. Diabetes Care. 2006;29(7):1545\u201353.","journal-title":"Diabetes Care"},{"issue":"7","key":"817_CR25","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1161\/01.STR.32.7.1539","volume":"32","author":"N Hosomi","year":"2001","unstructured":"Hosomi N, Mizushige K, Ohyama H, Takahashi T, Kitadai M, Hatanaka Y, et al. Angiotensin-converting enzyme inhibition with enalapril slows progressive intima-media thickening of the common carotid artery in patients with non-insulin-dependent diabetes mellitus. Stroke. 2001;32(7):1539\u201345.","journal-title":"Stroke"},{"issue":"12","key":"817_CR26","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1097\/gme.0b013e318259c04e","volume":"19","author":"M Igase","year":"2012","unstructured":"Igase M, Kohara K, Tabara Y, Nagai T, Ochi N, Kido T, et al. Low-dose rosuvastatin improves the functional and morphological markers of atherosclerosis in asymptomatic postmenopausal women with dyslipidemia. Menopause. 2012;19(12):1294\u20139.","journal-title":"Menopause."},{"issue":"3","key":"817_CR27","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.amjcard.2014.04.050","volume":"114","author":"S Ishikawa","year":"2014","unstructured":"Ishikawa S, Shimano M, Watarai M, Koyasu M, Uchikawa T, Ishii H, et al. Impact of sitagliptin on carotid intima-media thickness in patients with coronary artery disease and impaired glucose tolerance or mild Diabetes Mellitus. Am J Cardiol. 2014;114(3):384\u20138.","journal-title":"Am J Cardiol"},{"issue":"5","key":"817_CR28","first-page":"1421","volume":"52","author":"N Katakami","year":"2010","unstructured":"Katakami N, Kim YS, Kawamori R, Yamasaki Y. The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects with type 2 diabetes mellitus: principal results of the Diabetic Atherosclerosis Prevention by Cilostazol (DAPC) study: a randomized trial. Circulation. 2010;52(5):1421\u20139.","journal-title":"Circulation"},{"issue":"4","key":"817_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0049-3848(99)00168-1","volume":"97","author":"M Kodama","year":"2000","unstructured":"Kodama M, Yamasaki Y, Sakamoto K, Yoshioka R, Matsuhisa M, Kajimoto Y, et al. Antiplatelet drugs attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes. Thromb Res. 2000;97(4):239\u201345.","journal-title":"Thromb Res"},{"key":"817_CR30","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1097\/00005344-199906000-00009","volume":"33","author":"H Koshiyama","year":"1999","unstructured":"Koshiyama H, Tanaka S, Minamikawa J. Effect of calcium channel blocker amlodipine on the intima-media thickness of carotid arterial wall in type 2 diabetes. J Cardiovasc Pharmacol. 1999;33:894\u20136.","journal-title":"J Cardiovasc Pharmacol"},{"key":"817_CR31","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1210\/jcem.86.7.7810","volume":"86","author":"H Koshiyama","year":"2001","unstructured":"Koshiyama H, Shimono D, Kuwamura N, Minamikawa J, Nakamura Y. Inhibitory effect of pioglitazone on carotid arterial wall thickness in type 2 diabetes. J Clin Endocrinol Metab. 2001;86:3452\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"817_CR32","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.clinthera.2010.07.015","volume":"32","author":"M Koyasu","year":"2010","unstructured":"Koyasu M, Ishii H, Watarai MK, Inden Y, Takeshita K, Amano T, et al. Impact of acarbose on carotid intima-media thickness in patients with newly diagnosed impaired glucose tolerance or mild type 2 diabetes mellitus: a one-year, prospective, randomized, open-label, parallel-group study in Japanese adults with established cor. Clin Ther. 2010;32(9):1610\u20137.","journal-title":"Clin Ther"},{"issue":"12","key":"817_CR33","first-page":"22","volume":"14","author":"MR Langenfeld","year":"2005","unstructured":"Langenfeld MR, Forst T, Hohberg C. Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus: results from a controlled randomized study. Circulation. 2005;14(12):22\u20139.","journal-title":"Circulation"},{"issue":"22","key":"817_CR34","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1016\/j.jacc.2008.12.072","volume":"53","author":"EM Lonn","year":"2009","unstructured":"Lonn EM, Gerstein HC, Sheridan P, Smith S, Diaz R, Mohan V, et al. Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone). J Am College Cardiol. 2009;53(22):2036\u20138.","journal-title":"J Am College Cardiol."},{"issue":"7","key":"817_CR35","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/S0149-2918(02)80028-5","volume":"24","author":"M Ludwig","year":"2002","unstructured":"Ludwig M, Stapff M, Ribeiro A, Fritschka E, Tholl U, Smith RD, et al. Comparison of the effects of losartan and atenolol on common carotid artery intima-media thickness in patients with hypertension: results of a 2-year, double-blind, randomized, controlled study. Clin Ther. 2002;24(7):1175\u201393.","journal-title":"Clin Ther"},{"issue":"21","key":"817_CR36","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1001\/jama.296.21.joc60158","volume":"296","author":"T Mazzone","year":"2006","unstructured":"Mazzone T, Meyer PM, Feinstein SB, Davidson MH, Kondos GT, D\u2019Agostino RB, et al. Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial. JAMA. 2006;296(21):2572\u201381.","journal-title":"JAMA"},{"key":"817_CR37","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1210\/jcem.83.5.4932","volume":"83","author":"J Minamikawa","year":"1998","unstructured":"Minamikawa J, Tanaka S, Yamauchi M, Inoue D, Koshiyama H. Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes. J Clin Endocrinol Metab. 1998;83:1818\u201320.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"817_CR38","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1161\/ATVBAHA.107.152835","volume":"27","author":"T Mita","year":"2007","unstructured":"Mita T, Watada H, Shimizu T, Tamura Y, Sato F, Watanabe T, et al. Nateglinide reduces carotid intima-media thickening in type 2 diabetic patients under good glycemic control. Arterioscler Thromb Vasc Biol. 2007;27(11):2456\u201362.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"817_CR39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2337\/dc15-0781","volume":"39","author":"T Mita","year":"2016","unstructured":"Mita T, Katakami N, Yoshii H, Onuma T, Kaneto H, Osonoi T, et al. Alogliptin, a dipeptidyl peptidase 4 inhibitor, prevents the progression of carotid atherosclerosis in patients with type 2 diabetes: the Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A). Diabetes Care. 2016;39(1):139\u201348.","journal-title":"Diabetes Care"},{"issue":"3","key":"817_CR40","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2337\/dc15-2145","volume":"39","author":"T Mita","year":"2016","unstructured":"Mita T, Katakami N, Shiraiwa T, Yoshii H, Onuma T, Kuribayashi N, et al. Sitagliptin attenuates the progression of carotid intima-media thickening in insulin-treated patients with type 2 diabetes: the Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): A randomized controlled trial. Diabetes Care. 2016;39(3):455\u201364.","journal-title":"Diabetes Care"},{"issue":"6","key":"817_CR41","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1507\/endocrj.51.545","volume":"51","author":"N Mitsuhashi","year":"2004","unstructured":"Mitsuhashi N, Tanaka Y, Kubo S, Ogawa S, Hayashi C, Uchino H, et al. Effect of cilostazol, a phosphodiesterase inhibitor, on carotid IMT in Japanese type 2 diabetic patients. Endocr J. 2004;51(6):545\u201350.","journal-title":"Endocr J."},{"issue":"5","key":"817_CR42","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/j.1365-2796.2007.01775.x","volume":"261","author":"D M\u00f6rtsell","year":"2010","unstructured":"M\u00f6rtsell D, Malmqvist K, Held C, Kahan T. Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study. J Intern Med. 2010;261(5):472\u20139.","journal-title":"J Intern Med"},{"issue":"10","key":"817_CR43","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1016\/j.metabol.2004.05.013","volume":"53","author":"T Nakamura","year":"2004","unstructured":"Nakamura T, Matsuda T, Kawagoe Y, Ogawa H, Takahashi Y, Sekizuka K, et al. Effect of pioglitazone on carotid intima-media thickness and arterial stiffness in type 2 diabetic nephropathy patients. Metabolism. 2004;53(10):1382\u20136.","journal-title":"Metabolism."},{"issue":"4","key":"817_CR44","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3109\/10641963.2013.780074","volume":"35","author":"Y Ohta","year":"2013","unstructured":"Ohta Y, Kawano Y, Iwashima Y, Hayashi S, Yoshihara F, Matayoshi T, et al. Control of home blood pressure with an amlodipine- or losartan-based regimen and progression of carotid artery intima-media thickness in hypertensive patients: the HOSP substudy. Clin Exp Hypertens. 2013;35(4):279\u201384.","journal-title":"Clin Exp Hypertens."},{"key":"817_CR45","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/08037050510034185","volume":"14","author":"MH Olsen","year":"2005","unstructured":"Olsen MH, Wachtell K, Neland K, Bella JN, Rokkedal J, Dige-Petersen H, et al. Losartan but not atenolol reduces carotid artery hypertrophy in essential hypertension. A LIFE substudy. Blood Press. 2005;14:177\u201383.","journal-title":"Blood Press."},{"issue":"3","key":"817_CR46","doi-asserted-by":"publisher","first-page":"154","DOI":"10.5551\/jat.E549","volume":"15","author":"T Oyama","year":"2008","unstructured":"Oyama T, Saiki A, Endoh K, Ban N, Nagayama D, Ohhira M, et al. Effect of acarbose, an alpha-glucosidase inhibitor, on serum lipoprotein lipase mass levels and common carotid artery intima-media thickness in type 2 diabetes mellitus treated by sulfonylurea. J Atheroscler Thromb. 2008;15(3):154\u20139.","journal-title":"J Atheroscler Thromb."},{"issue":"6","key":"817_CR47","doi-asserted-by":"publisher","first-page":"e1002051","DOI":"10.1371\/journal.pmed.1002051","volume":"13","author":"J Oyama","year":"2016","unstructured":"Oyama J, Murohara T, Kitakaze M, Ishizu T, Sato Y, Kitagawa K, et al. The Effect of sitagliptin on carotid artery atherosclerosis in type 2 diabetes: the PROLOGUE Randomized Controlled Trial. PLoS Med. 2016;13(6):e1002051. https:\/\/doi.org\/10.1371\/journal.pmed.1002051 .","journal-title":"PLoS Med."},{"issue":"7","key":"817_CR48","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/dmrr.2433","volume":"29","author":"YR Patel","year":"2013","unstructured":"Patel YR, Kirkman MS, Considine RV, Hannon TS, Mather KJ. Effect of acarbose to delay progression of carotid intima\u2013media thickness in early diabetes. Diabetes Metab Res Rev. 2013;29(7):582\u201391.","journal-title":"Diabetes Metab Res Rev"},{"issue":"4","key":"817_CR49","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/S0735-1097(01)01783-1","volume":"39","author":"Y Sawayama","year":"2002","unstructured":"Sawayama Y, Shimizu C, Maeda N, Tatsukawa M, Kinukawa N, Koyanagi S, et al. Effects of probucol and pravastatin on common carotid atherosclerosis in patients with asymptomatic hypercholesterolemia. Fukuoka Atherosclerosis Trial (FAST). J Am Coll Cardiol. 2002;39(4):610\u20136.","journal-title":"J Am Coll Cardiol."},{"issue":"2","key":"817_CR50","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s00125-001-0740-2","volume":"45","author":"T Shinoda-Tagawa","year":"2002","unstructured":"Shinoda-Tagawa T, Yamasaki Y, Yoshida S, Kajimoto Y, Tsujino T, Hakui N, et al. A phosphodiesterase inhibitor, cilostazol, prevents the onset of silent brain infarction in Japanese subjects with Type II diabetes. Diabetologia. 2002;45(2):188\u201394.","journal-title":"Diabetologia"},{"issue":"5","key":"817_CR51","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1161\/01.ATV.0000124890.40436.77","volume":"24","author":"JS Sidhu","year":"2004","unstructured":"Sidhu JS, Kaposzta Z, Markus HS, Kaski JC. Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus. Arterioscler Thromb Vasc Biol. 2004;24(5):930.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"817_CR52","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1042\/cs1010455","volume":"101","author":"AV Stanton","year":"2001","unstructured":"Stanton AV, Chapman JN, Mayet J, Sever PS, Poulter NR, Hughes AD, et al. Effects of blood pressure lowering with amlodipine or lisinopril on vascular structure of the common carotid artery. Clin Sci (Lond). 2001;101:455\u201364.","journal-title":"Clin Sci (Lond)."},{"issue":"2","key":"817_CR53","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/1753944707085982","volume":"1","author":"KO Stumpe","year":"2007","unstructured":"Stumpe KO, Agabitirosei E, Zielinski T, Schremmer D, Scholze J, Laeis P, et al. Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study. Ther Adv Cardiovasc Dis. 2007;1(2):97\u2013106.","journal-title":"Ther Adv Cardiovasc Dis."},{"issue":"2","key":"817_CR54","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1161\/hs0202.102332","volume":"33","author":"O Wiklund","year":"2002","unstructured":"Wiklund O, Hulthe J, Wikstrand J, Schmidt C, Olofsson SO, Bondjers G. Effect of controlled release\/extended release metoprolol on carotid intima-media thickness in patients with hypercholesterolemia: a 3-year randomized study. Stroke. 2002;33(2):572\u20137.","journal-title":"Stroke"},{"key":"817_CR55","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1210\/jc.2004-1685","volume":"90","author":"AH Xiang","year":"2005","unstructured":"Xiang AH, Peters RK, Kjos SL, Ochoa C, Marroqin A, Goico J, et al. Effect of thiazolidinedione treatment on progression of subclinical atherosclerosis in postmenopausal women at high risk for type 2 diabetes. J Clin Endocrinol Metabol. 2005;90:1986\u201391.","journal-title":"J Clin Endocrinol Metabol."},{"issue":"3","key":"817_CR56","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/hr.2010.237","volume":"34","author":"K Yamamoto","year":"2010","unstructured":"Yamamoto K, Ozaki H, Takayasu K, Akehi N, Fukui S, Sakai A, et al. The Effect of losartan and amlodipine on left ventricular diastolic function and atherosclerosis in Japanese patients with mild-to-moderate hypertension (J-ELAN) study. Hypertens Res. 2010;34(3):325\u201330.","journal-title":"Hypertens Res."},{"key":"817_CR57","doi-asserted-by":"publisher","DOI":"10.1111\/j.2040-1124.2010.00064.x","author":"E Yasunari","year":"2011","unstructured":"Yasunari E, Takeno K, Funayama H, Tomioka S, Tamaki M, Fujitani Y, et al. Efficacy of pioglitazone on glycemic control and carotid intima-media thickness in type 2 diabetes patients with inadequate insulin therapy. J Diabetes Investig. 2011. https:\/\/doi.org\/10.1111\/j.2040-1124.2010.00064.x .","journal-title":"J Diabetes Investig."},{"issue":"1","key":"817_CR58","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.atherosclerosis.2011.09.048","volume":"220","author":"DF Geng","year":"2012","unstructured":"Geng DF, Deng J, Jin DM, Wu W, Wang JF. Effect of cilostazol on the progression of carotid intima-media thickness: a meta-analysis of randomized controlled trials. Atherosclerosis. 2012;220(1):177\u201383.","journal-title":"Atherosclerosis."},{"issue":"4","key":"817_CR59","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1161\/01.HYP.0000158263.64320.eb","volume":"45","author":"MJ Kim","year":"2005","unstructured":"Kim MJ, Park KG, Lee KM, Kim HS, Kim SY, Kim CS, et al. Cilostazol inhibits vascular smooth muscle cell growth by downregulation of the transcription factor E2F. Hypertension. 2005;45(4):552\u20136.","journal-title":"Hypertension"},{"issue":"2","key":"817_CR60","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.atherosclerosis.2009.06.016","volume":"207","author":"KM Lee","year":"2009","unstructured":"Lee KM, Lee HJ, Kim MK, Kim HS, Jung GS, Hur SH, et al. Cilostazol inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor expression in artery wall and neointimal region after vascular injury. Atherosclerosis. 2009;207(2):391\u20138.","journal-title":"Atherosclerosis."},{"key":"817_CR61","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1097\/00005344-199805000-00019","volume":"31","author":"O Stepien","year":"1998","unstructured":"Stepien O, Gogusev J, Zhu DL, Iouzalen L, Herembert T, Drueke TB, et al. Amlodipine inhibition of serum-, thrombin-, or fibroblast growth factor-induced vascular smooth-muscle cell proliferation. J Cardiovasc Pharmacol. 1998;31:786\u201393.","journal-title":"J Cardiovasc Pharmacol"},{"key":"817_CR62","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1161\/01.CIR.97.6.576","volume":"95","author":"X Zhang","year":"1998","unstructured":"Zhang X, Hintze TH. Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent. Circulation. 1998;95:576\u201380.","journal-title":"Circulation"},{"key":"817_CR63","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1097\/00004872-200018100-00010","volume":"18","author":"P Cristofori","year":"2000","unstructured":"Cristofori P, Lanzoni A, Quartaroli M, Pastorino AM, Zancanaro C, Cominacini L, et al. The calcium-channel blocker lacidipine reduces the development of atherosclerotic lesions in the apoE deficient mouse. J Hypertens. 2000;18:1429\u201336.","journal-title":"J Hypertens"},{"issue":"8","key":"817_CR64","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1097\/00004872-200108000-00005","volume":"19","author":"S Taddei","year":"2001","unstructured":"Taddei S, Virdis A, Ghiadoni L, Magagna A, Pasini AF, Garbin U, Cominacini L, Salvetti A. Effect of calcium antagonist or beta blockade treatment on nitric oxide-dependent vasodilation and oxidative stress in essential hypertensive patients. J Hypertens. 2001;19(8):1379\u201386.","journal-title":"J Hypertens"},{"key":"817_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/IBPC.S5174","volume":"2","author":"C Cuspidi","year":"2009","unstructured":"Cuspidi C, Negri F, Giudici V, Capra A, Sala C. Effects of antihypertensive drugs on carotid intima-media thickness: Focus on angiotensin II receptor blockers. A review of randomized, controlled trials. Integr Blood Press Control. 2009;2:1\u20138.","journal-title":"Integr Blood Press Control."},{"issue":"1","key":"817_CR66","doi-asserted-by":"publisher","first-page":"108","DOI":"10.5551\/jat.14001","volume":"20","author":"Y Huang","year":"2013","unstructured":"Huang Y, Li W, Dong L, Li R, Wu Y. Effect of statin therapy on the progression of common carotid artery intima-media thickness: an updated systematic review and meta-analysis of randomized controlled trials. J Atheroscler Thromb. 2013;20(1):108\u201321.","journal-title":"J Atheroscler Thromb."},{"issue":"1","key":"817_CR67","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.atherosclerosis.2011.05.004","volume":"218","author":"DF Geng","year":"2011","unstructured":"Geng DF, Jin DM, Wu W, Fang C, Wang JF. Effect of alpha-glucosidase inhibitors on the progression of carotid intima-media thickness: a meta-analysis of randomized controlled trials. Atherosclerosis. 2011;218(1):214\u20139.","journal-title":"Atherosclerosis."},{"key":"817_CR68","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/1925305","author":"T Mita","year":"2017","unstructured":"Mita T, Katakami N, Shiraiwa T, Yoshii H, Gosho M, Shimomura I, et al. The effect of sitagliptin on the regression of carotid intima-media thickening in patients with type 2 diabetes mellitus: a post hoc analysis of the sitagliptin preventive study of intima-media thickness evaluation. Int J Endocrinol. 2017. https:\/\/doi.org\/10.1155\/2017\/1925305 .","journal-title":"Int J Endocrinol."},{"issue":"16","key":"817_CR69","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1161\/CIRCULATIONAHA.107.746610","volume":"117","author":"M Davidson","year":"2008","unstructured":"Davidson M, Meyer PM, Haffner S, Feinstein S, D\u2019Agostino R Sr, Kondos GT, et al. Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus. Circulation. 2008;117(16):2123\u201330.","journal-title":"Circulation"},{"issue":"1","key":"817_CR70","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2010.02.011","volume":"212","author":"J Labreuche","year":"2010","unstructured":"Labreuche J, Deplanque D, Touboul PJ, Bruckert E, Amarenco P. Association between change in plasma triglyceride levels and risk of stroke and carotid atherosclerosis: systematic review and meta-regression analysis. Atherosclerosis. 2010;212(1):9\u201315.","journal-title":"Atherosclerosis."},{"key":"817_CR71","doi-asserted-by":"publisher","first-page":"10202","DOI":"10.1038\/srep10202","volume":"5","author":"X Song","year":"2015","unstructured":"Song X, Jia H, Jiang Y, Wang L, Zhang Y, Mu Y, Liu Y. Anti-atherosclerotic effects of the glucagon-like peptide-1 (GLP-1) based therapies in patients with type 2 Diabetes Mellitus: a meta-analysis. Sci Rep. 2015;5:10202. https:\/\/doi.org\/10.1038\/srep10202 .","journal-title":"Sci Rep."},{"issue":"1","key":"817_CR72","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12933-018-0695-y","volume":"17","author":"C Irace","year":"2018","unstructured":"Irace C, Casciaro F, Scavelli FB, Oliverio R, Cutruzzol\u00e0 A, Cortese C, Gnasso A. Empagliflozin influences blood viscosity and wall shear stress in subjects with type 2 diabetes mellitus compared with incretin-based therapy. Cardiovasc Diabetol. 2018;17(1):52. https:\/\/doi.org\/10.1186\/s12933-018-0695-y .","journal-title":"Cardiovasc Diabetol."},{"issue":"1","key":"817_CR73","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12933-018-0666-3","volume":"17","author":"N Katakami","year":"2018","unstructured":"Katakami N, Mita T, Irie Y, Takahara M, Matsuoka TA, Gosho M, et al. Effect of sitagliptin on tissue characteristics of the carotid wall in patients with type 2 diabetes: a post hoc sub-analysis of the sitagliptin preventive study of intima-media thickness evaluation (SPIKE). Cardiovasc Diabetol. 2018;17(1):24. https:\/\/doi.org\/10.1186\/s12933-018-0666-3 .","journal-title":"Cardiovasc Diabetol."},{"issue":"1","key":"817_CR74","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-017-0646-z","volume":"17","author":"V Lambadiari","year":"2018","unstructured":"Lambadiari V, Pavlidis G, Kousathana F, Varoudi M, Vlastos D, Maratou E, et al. Effects of 6-month treatment with the glucagon like peptide-1 analogue liraglutide on arterial stiffness, left ventricular myocardial deformation and oxidative stress in subjects with newly diagnosed type 2 diabetes. Cardiovasc Diabetol. 2018;17(1):8. https:\/\/doi.org\/10.1186\/s12933-017-0646-z .","journal-title":"Cardiovasc Diabetol."},{"key":"817_CR75","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1093\/oxfordjournals.aje.a116642","volume":"137","author":"CM Burchfiel","year":"1993","unstructured":"Burchfiel CM, Reed DM, Marcus EB, Strong JP, Hayashi T. Associations of diabetes mellitus with coronary atherosclerosis and myocardial lesions: an autopsy study from the Honolulu Heart Program. Am J Epidemiol. 1993;137:1328\u201340.","journal-title":"Am J Epidemiol"},{"key":"817_CR76","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1161\/01.STR.25.1.66","volume":"25","author":"AR Folsom","year":"1994","unstructured":"Folsom AR, Eckfeldt HJ, Weitzman S, Ma J, Chambless LE, Barnes RW, et al. Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity. Stroke. 1994;25:66\u201373.","journal-title":"Stroke"},{"issue":"10","key":"817_CR77","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.2337\/diacare.15.10.1290","volume":"15","author":"R Kawamori","year":"1992","unstructured":"Kawamori R, Yamasaki Y, Matsushima H, Nishizawa H, Nao K, Hougaku H, et al. Prevalence of carotid atherosclerosis in diabetic patients. Ultrasound high-resolution B-mode imaging on carotid arteries. Diabetes Care. 1992;15(10):1290\u20134.","journal-title":"Diabetes Care."},{"key":"817_CR78","doi-asserted-by":"publisher","first-page":"276","DOI":"10.2337\/diacare.20.3.276","volume":"3","author":"S Kanters","year":"1997","unstructured":"Kanters S, Alga A, Banga JD. Carotid intima-media thickness in hyperlipidemic type I and type II diabetic patients. Diabetes Care. 1997;3:276\u201380.","journal-title":"Diabetes Care"},{"key":"817_CR79","first-page":"Ab495","volume":"35","author":"CF Alonso","year":"2018","unstructured":"Alonso CF, Barshop R, Galazka P, Li S, Chen W, Berenson GS. Body mass index is associated with progression of carotid intima-media thickness in black, but not in white young adults: The Bogalusa Heart Study. Arterioscler Thromb Vasc Biol. 2018;35:Ab495.","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"817_CR80","doi-asserted-by":"publisher","DOI":"10.1002\/jum.14673","author":"AA Asaleye","year":"2018","unstructured":"Asaleye AA, Braimoh KT, Oyinloye OI, Asaleye CM, Omisore AD. Variation of carotid intima media thickness with body mass index in healthy adults of black African descent. J Ultrasound Med. 2018. https:\/\/doi.org\/10.1002\/jum.14673 .","journal-title":"J Ultrasound Med."},{"issue":"4","key":"817_CR81","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4103\/1596-3519.142274","volume":"13","author":"OU Eric","year":"2014","unstructured":"Eric OU, Atinuke MA, Abiodun OA, Ademola JA. Body mass index as a determinant of carotid intima-media thickness in Nigerian adults with primary hypertension. Ann Afr Med. 2014;13(4):151\u20136.","journal-title":"Ann Afr Med."},{"key":"817_CR82","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.107.696385","author":"T Rundek","year":"2007","unstructured":"Rundek T, Brook RD, Spence JD. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007. https:\/\/doi.org\/10.1161\/circulationaha.107.696385 .","journal-title":"Circulation."}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-019-0817-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12933-019-0817-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-019-0817-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T12:07:20Z","timestamp":1720958840000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-019-0817-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,30]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["817"],"URL":"https:\/\/doi.org\/10.1186\/s12933-019-0817-1","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,30]]},"assertion":[{"value":"31 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"14"}}